The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?-Reference-Cited by-同舟云学术

The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?

Published:2021-07 Issue: Volume:52 Page:102968
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Sen S.^ORCID,Karabudak R.,Schiavetti I.,Demir S.,Ozakbas S.,Tutuncu M.,Petek Balci B.,Turan O.F.,Uzunkopru C.,Koseoglu M.,Yetkin M.F.,Gunduz T.^ORCID,Gumus H.,Kale Icen N.,Carmisciano L.^ORCID,Terzi M.,Acar P.,Gungor Dogan I.,Baba C.,Tuncer A.,Uygunoglu U.,Sormani M.P.,Efendi H.^ORCID,Siva A.^ORCID

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference25 articles.

1. Prevalence and clinical outcomes of Covid-19 in patients with autoimmune diseases: a systematic review and meta-analysis;Akiyama;Ann. Rheum. Dis.,2020

2. Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?;Altobrando;J. Eur. Acad. Dermatol. Venereol.,2020

3. The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic;Baker;Mult. Scler. Relat. Disord.,2020

4. Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity;Browne;Neurology,2014

5. Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study;Costa;Neurol. Sci.,2020

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of mRNA versus inactivated Covid-19 vaccine responses with smoking in Multiple Sclerosis;Archives of Neuropsychiatry;2023

2. Immune responses following COVID-19 infection in multiple sclerosis patients using immunomodulatory therapy;Acta Neurologica Belgica;2022-11-04

3. Signs and symptoms of COVID‐19 in patients with multiple sclerosis;European Journal of Neurology;2022-09-23

4. The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study;Multiple Sclerosis and Related Disorders;2022-09

5. SARS-CoV-2 infection in patients with neuroimmunological disorders in a tertiary referral centre from the north of Portugal;Multiple Sclerosis and Related Disorders;2022-07